Canine cTnT antibody and antigen (recombinant protein)
Diagnostic anti-Canine cTnT antibodies pairs and antigen for animal health (animal Dog/Canine hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. ) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-cTnT-Ag01 | Canine cTnT | $3090.00 |
GMP-CAN-cTnT-Ab01 | Anti-Canine cTnT mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-cTnT-Ab02 | Anti-Canine cTnT mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-cTnT-Ab03 | Anti-Canine cTnT human monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-cTnT-Ab04 | Anti-Canine cTnT human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-CAN-cTnT-Ag01 |
Product Name | Canine cTnT |
Target/Biomarker | Canine cTnT |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine cTnT antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cTnT level test of animal Dog/Canine with hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. . |
Tag | His | Reconized/Reactive Specics | Canine cTnT |
Product description | Recombinant Canine cTnT protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-cTnT-Ab01,GMP-CAN-cTnT-Ab02 |
Target/Biomarker | Canine cTnT |
Product Name | Anti-Canine cTnT mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine cTnT antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine cTnT antibodies in Canine cTnT level test of animal Dog/Canine with hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. . |
Product description | Anti-Canine cTnT mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine cTnT antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-cTnT-Ab03,GMP-CAN-cTnT-Ab04 |
Target/Biomarker | Canine cTnT |
Product Name | Anti-Canine cTnT human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Canine cTnT antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine cTnT antibodies in Canine cTnT level test of animal Dog/Canine with hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. . |
Product description | Anti-Canine cTnT mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Cardiac Troponin T (cTnT) in dogs is a specialized protein that plays a critical role in the regulation of muscle contraction in the heart. It is a component of the troponin complex, a set of proteins that control the interaction between actin and myosin, facilitating cardiac muscle contraction. Importantly, cTnT is unique to cardiac muscle cells, making it a highly specific biomarker for heart-related issues.
When cardiac muscle cells in the dog's heart become damaged or stressed, cTnT is released into the bloodstream. This release occurs due to the disruption of the sarcomere structure in cardiac muscle, which allows cTnT to escape from the cells. As a result, cTnT levels in the blood become elevated, serving as a clear indicator of cardiac muscle injury.
Veterinarians utilize cTnT measurements to diagnose cardiac conditions in dogs accurately. These measurements help confirm the presence of cardiac muscle damage, determine its extent, and guide treatment strategies. Monitoring cTnT levels over time enables veterinarians to assess the progress of treatment and the overall cardiac health of canine patients.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.